Jingjing Zhao

机构：Shanghai Medical College of Fudan University, Army Medical University, Fudan University, Fudan University Shanghai Cancer Center, Southwest Hospital · ORCID：0000-0002-9880-508X

发表论文 97 篇 · 总被引 1930 次 · h-index 25

代表论文

• Tenecteplase Thrombolysis for Stroke up to 24 Hours After Onset With Perfusion Imaging Selection: The CHABLIS-T II Randomized Clinical Trial (2025 · Stroke · 被引 43)
• XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial (2024 · Signal Transduction and Targeted Therapy · 被引 35)
• FGFR4-specific CAR-T cells with inducible caspase-9 suicide gene as an approach to treat rhabdomyosarcoma (2024 · Cancer Gene Therapy · 被引 33)
• Circular RNA landscape in extracellular vesicles from human biofluids (2024 · Genome Medicine · 被引 26)
• Unrevealing the therapeutic benefits of radiotherapy and consolidation immunotherapy using ctDNA-defined tumor clonality in unresectable locally advanced non-small cell lung cancer (2023 · Cancer Letters · 被引 16)
• The impact of “long COVID” on menstruation in Chinese female college students and the intervention of acupuncture (2024 · Medicine · 被引 8)